Investment Thesis
HBM Partners invests in venture, growth, and buy-out financings and public companies in biopharma, medtech, diagnostics, and healthcare across Europe, North America, and emerging markets.
Stage Focus
Early-stage to growth-stage (USD 5M–50M investments)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Venture, growth, and buy-out financings for private companies; investments in public companies
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€4,600,000 - €46,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
